×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Gastric Balloon Market

ID: MRFR/HC/40777-HCR
128 Pages
Rahul Gotadki
October 2025

Gastric Balloon Market Research Report By Type (Single Balloon, Dual Balloon, Triple Balloon), By Material (Silicone, Polyurethane, Latex), By End User (Hospitals, Ambulatory Surgical Centers, Clinics), By Distribution Channel (Direct Sales, Online Sales, Third-party Distributors) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gastric Balloon Market Infographic
Purchase Options

Gastric Balloon Market Summary

As per MRFR analysis, the Gastric Balloon Market Size was estimated at 2.386 USD Billion in 2024. The Gastric Balloon industry is projected to grow from 2.552 USD Billion in 2025 to 5.011 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.98 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Gastric Balloon Market is experiencing robust growth driven by technological advancements and rising health consciousness.

  • North America remains the largest market for gastric balloons, reflecting a strong demand for weight management solutions.
  • The Asia-Pacific region is identified as the fastest-growing market, indicating a shift in consumer preferences towards non-surgical options.
  • The Single Balloon segment holds the largest market share, while the Dual Balloon segment is rapidly gaining traction due to its innovative approach.
  • Increasing obesity rates and advancements in medical technology are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 2.386 (USD Billion)
2035 Market Size 5.011 (USD Billion)
CAGR (2025 - 2035) 6.98%

Major Players

Apollo Endosurgery (US), Medtronic (US), Obalon Therapeutics (US), ReShape Lifesciences (US), Allergan (US), EndoChoice (US), Spatz FGIA (US), Bariatric Solutions (US)

Gastric Balloon Market Trends

The Gastric Balloon Market is currently experiencing a notable transformation, driven by increasing awareness of obesity-related health issues and the rising demand for non-invasive weight loss solutions. As individuals seek alternatives to surgical procedures, the popularity of gastric balloons has surged. This trend is further supported by advancements in technology, which have enhanced the safety and efficacy of these devices. Moreover, the growing emphasis on preventive healthcare is prompting more people to consider gastric balloons as a viable option for weight management. In addition, the Gastric Balloon Market is witnessing a shift in consumer demographics, with a broader range of age groups exploring these options. This diversification indicates a potential for market expansion, as younger individuals become more health-conscious and seek effective methods for weight control. Furthermore, the increasing availability of gastric balloon procedures in various healthcare settings, including outpatient clinics, is likely to contribute to market growth. As the landscape evolves, stakeholders must remain vigilant to emerging trends and consumer preferences to capitalize on the opportunities within this dynamic market.

Technological Advancements

Recent innovations in gastric balloon design and materials are enhancing patient safety and comfort. These advancements may lead to improved outcomes and higher satisfaction rates among users.

Rising Health Consciousness

An increasing awareness of obesity and its associated health risks is driving more individuals to seek non-invasive weight loss ingredients solutions. This trend suggests a growing acceptance of gastric balloons as a practical option.

Diverse Consumer Base

The Gastric Balloon Market is expanding to include a wider demographic, with younger individuals showing interest in weight management solutions. This shift indicates potential for broader market reach and engagement.

Gastric Balloon Market Drivers

Increasing Obesity Rates

The rising prevalence of obesity is a critical driver for the Gastric Balloon Market. According to recent statistics, obesity rates have escalated, with approximately 39% of adults classified as overweight or obese. This alarming trend has prompted a surge in demand for effective weight loss solutions, including gastric balloons. As individuals seek non-surgical options, the Gastric Balloon Market is positioned to benefit significantly. The increasing awareness of obesity-related health risks, such as diabetes and cardiovascular diseases, further fuels the need for innovative weight management solutions. Consequently, healthcare providers are more likely to recommend gastric balloons as a viable alternative, thereby expanding the market's reach and potential.

Evolving Consumer Preferences

Consumer preferences are shifting towards less invasive and more effective weight loss solutions, significantly impacting the Gastric Balloon Market. As individuals become more health-conscious, they are increasingly seeking alternatives to traditional dieting and exercise. Gastric balloons, which provide a non-surgical option for weight management, align with these evolving preferences. Market Research Future indicates that consumers are more inclined to choose solutions that offer convenience and minimal disruption to their daily lives. This trend is further supported by the growing availability of gastric balloon procedures in various healthcare settings, making them more accessible. As consumer preferences continue to evolve, the Gastric Balloon Market is likely to experience sustained growth.

Rising Healthcare Expenditure

The increase in healthcare expenditure is another driving force behind the Gastric Balloon Market. As countries allocate more resources to healthcare, there is a growing emphasis on preventive measures and weight management solutions. This trend is particularly evident in regions where healthcare systems are evolving to address the obesity epidemic. Increased funding for obesity treatment programs and initiatives has led to greater accessibility of gastric balloon procedures. Additionally, insurance coverage for non-surgical weight loss options is expanding, making gastric balloons more affordable for patients. This shift in healthcare expenditure priorities is likely to bolster the Gastric Balloon Market, as more individuals seek these effective weight loss solutions.

Advancements in Medical Technology

Technological innovations play a pivotal role in shaping the Gastric Balloon Market. Recent advancements in balloon design and materials have enhanced the safety and efficacy of these devices. For instance, the introduction of adjustable gastric balloons allows for personalized treatment plans, catering to individual patient needs. Furthermore, minimally invasive procedures have gained traction, reducing recovery times and improving patient satisfaction. The integration of digital health technologies, such as mobile applications for monitoring progress, also contributes to the appeal of gastric balloons. As these advancements continue to evolve, they are likely to attract a broader audience, thereby driving growth within the Gastric Balloon Market.

Growing Awareness of Non-Surgical Options

The increasing awareness of non-surgical weight loss options is a significant driver for the Gastric Balloon Market. Many individuals are hesitant to undergo invasive surgical procedures due to associated risks and recovery times. Gastric balloons offer a less invasive alternative, appealing to those seeking effective weight management solutions without the need for surgery. Educational campaigns and healthcare provider recommendations have contributed to this awareness, leading to a rise in demand. Market data indicates that the non-surgical weight loss segment is expected to grow substantially, with gastric balloons being a prominent choice among patients. This trend suggests a favorable outlook for the Gastric Balloon Market as more individuals opt for non-invasive solutions.

Market Segment Insights

By Type: Single Balloon (Largest) vs. Dual Balloon (Fastest-Growing)

In the Gastric Balloon Market, the segments of Single Balloon, Dual Balloon, and Triple Balloon have distinct market share distributions, with the Single Balloon category leading as the largest segment. This dominance is attributed to its established efficacy and popularity among practitioners and patients alike. Conversely, the Dual Balloon segment is rapidly gaining traction, appealing to a broader consumer base seeking innovative solutions for weight loss and obesity management. The Triple Balloon is less prominent, representing a smaller share of the market but still contributing to the diverse offerings in gastric balloon technology.

Single Balloon (Dominant) vs. Dual Balloon (Emerging)

The Single Balloon segment remains the dominant player in the Gastric Balloon Market, celebrated for its simplicity and effectiveness in aiding weight loss. It is favored among healthcare professionals for its ease of insertion and removal, making it a cost-effective option. On the other hand, the Dual Balloon segment is emerging as a valuable alternative, designed to enhance the satiety effect and improve weight loss outcomes. Its innovative approach, which utilizes two connected balloons, is appealing to patients looking for enhanced effectiveness. As healthcare providers continue to seek solutions with superior results, the Dual Balloon could become increasingly prominent in the market.

By Material: Silicone (Largest) vs. Polyurethane (Fastest-Growing)

In the Gastric Balloon Market, the material segment is primarily dominated by silicone, which is favored for its biocompatibility and durability. Silicone balloons generally command the largest market share due to their widespread acceptance among healthcare providers and patients alike. Polyurethane and latex are emerging segments, but they currently hold smaller shares in the overall market. Polyurethane is gaining attention for its unique properties, making it a popular alternative in newer product lines, while latex is witnessing limited adoption due to allergy concerns.

Silicone (Dominant) vs. Polyurethane (Emerging)

Silicone gastric balloons are known for their flexibility and strength, making them the dominant choice in bariatric procedures. Their established safety and efficacy records contribute to their sustained market leadership. Silicone balloons are widely endorsed by practitioners and have a strong consumer following. On the other hand, polyurethane balloons are seen as an emerging option, offering potential benefits such as increased comfort and reduced risk of deflation. As manufacturers explore innovative designs and performance enhancements, polyurethane's growth trajectory is expected to accelerate, drawing interest from both healthcare professionals and patients seeking effective weight loss solutions.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Gastric Balloon Market, hospitals account for the largest share of the end-user segment, driven by their advanced facilities and specialized healthcare professionals. Their capability to provide comprehensive care during the gastric balloon procedure enhances patient trust, thereby maintaining their dominance in this sector. Conversely, ambulatory surgical centers are rapidly gaining traction due to their efficiency and cost-effectiveness, appealing to patients seeking less invasive surgical options.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are the dominant force in the Gastric Balloon Market, offering extensive resources and support for patient management during weight loss procedures. With their established reputation, hospitals provide a range of services from pre-operative assessments to post-operative follow-ups, which ensures better care continuity. In contrast, ambulatory surgical centers are emerging as a popular choice for patients, primarily due to their lower costs and quicker recovery times. These centers facilitate same-day procedures, making them attractive for patients looking for convenience and efficiency. As patient preferences shift towards minimally invasive treatments and faster recovery, ambulatory surgical centers are expected to grow significantly.

By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the Gastric Balloon Market, the distribution channels are characterized by three main segments: Direct Sales, Online Sales, and Third-party Distributors. Direct Sales currently holds the largest share, owing to strong relationships between manufacturers and healthcare providers, providing a streamlined approach for patient access. Online Sales, while smaller in share, are rapidly gaining traction as patient preferences shift towards the convenience of e-commerce platforms for healthcare products.

Distribution Channels: Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct Sales in the Gastric Balloon Market represent a dominant channel, allowing manufacturers to establish direct relationships with healthcare providers and patients. This channel benefits from the personalized service typically associated with in-person consultations and enables continuous support throughout the treatment process. In contrast, Online Sales are emerging as a significant force, driven by the growing acceptance of telemedicine and a shift towards digital platforms. This channel offers convenience and accessibility, making it increasingly attractive for tech-savvy patients seeking gastric balloon solutions.

Get more detailed insights about Gastric Balloon Market

Regional Insights

The Global Gastric Balloon Market is steadily progressing, with various regions displaying unique characteristics and growth potential. In 2024, North America is projected to have a significant market valuation of 0.785 USD Billion, which is indicative of its dominance in the gastric balloon industry, driven by a growing prevalence of obesity and increasing healthcare affordability. Europe follows closely with a valuation of 0.661 USD Billion, reflecting its substantial healthcare infrastructure and rising awareness of weight management solutions.

The APAC region, valued at 0.413 USD Billion in 2024, shows promising growth, fueled by expanding medical tourism and increased acceptance of non-surgical weight loss solutions.

Meanwhile, South America and MEA are valued at 0.207 USD Billion and 0.314 USD Billion, respectively, highlighting their emerging markets with potential for growth driven by rising health consciousness and improved access to medical treatments. Overall, the Global Gastric Balloon Market revenue showcases significant regional variations, indicating diverse opportunities and challenges influenced by local healthcare dynamics and patient preferences.

Gastric Balloon Market Region

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Gastric Balloon Market Regional Image

Key Players and Competitive Insights

The Global Gastric Balloon Market is witnessing dynamic competition driven by the rising prevalence of obesity and associated health complications. This market is characterized by innovative developments in the design and efficacy of gastric balloons, which are non-surgical weight-loss devices. As consumer awareness increases and healthcare providers expand their offerings, various competitors are positioning themselves to capture a significant share of this growing market.

Competitive insights reveal that companies are focusing on enhancing patient satisfaction and outcomes through improved technology and personalized care strategies. The market landscape is shaped by factors such as regulatory approvals, partnerships, product launches, and clinical studies that validate the effectiveness of these gastric balloon systems.

Gastric Banding remains a significant player within the Global Gastric Balloon Market, capitalizing on its well-established procedures and a robust portfolio of products. The strength of Gastric Banding lies in its extensive experience and proven track record of patient outcomes. The company has developed a solid market presence thanks to its strategic focus on innovation and customer-centric solutions.

By continuously investing in research and development, Gastric Banding has been able to enhance the effectiveness of its products and provide tailored solutions to meet diverse patient needs. Furthermore, the company has established a network of partnerships with healthcare providers, ensuring wider accessibility and better utilization of its gastric balloon systems in clinical settings.

Acom Health plays a pivotal role in the Global Gastric Balloon Market by integrating technology and healthcare services to optimize patient management. The company is known for its commitment to educating both patients and healthcare providers about the benefits and proper usage of gastric balloons.

Acom Health leverages advanced data analytics and operational management systems to streamline the patient journey, ensuring that individuals receive comprehensive support before, during, and after the gastric balloon procedure. This holistic approach enhances patient outcomes and aligns with the company's goal of promoting healthier lifestyles. Acom Health's focus on technological innovation and commitment to quality care ensures it remains a competitive player in the evolving gastric balloon landscape.

Key Companies in the Gastric Balloon Market market include

Industry Developments

  • Q3 2022: Allurion launches swallowable gastric balloon capsule for weight loss in India Allurion announced the launch of its swallowable gastric balloon capsule in India, marking the introduction of the world’s first and only swallowable gastric balloon for weight loss, approved by the Central Drugs Standard Control Organization (CDSCO) in India.
  • Q1 2021: Apollo Endosurgery receives breakthrough device designation from U.S. FDA for Orbera Intragastric Balloon Apollo Endosurgery received the U.S. FDA's breakthrough device designation for its Orbera Intragastric Balloon, intended for treating patients with non-alcoholic steatohepatitis (NASH).

Future Outlook

Gastric Balloon Market Future Outlook

The Gastric Balloon Market is projected to grow at a 6.98% CAGR from 2024 to 2035, driven by increasing obesity rates, technological advancements, and rising consumer awareness.

New opportunities lie in:

  • Expansion of telehealth services for remote patient monitoring
  • Development of biodegradable gastric balloons for sustainability
  • Partnerships with fitness centers for integrated weight loss programs

By 2035, the Gastric Balloon Market is expected to achieve substantial growth and innovation.

Market Segmentation

Gastric Balloon Market Type Outlook

  • Single Balloon
  • Dual Balloon
  • Triple Balloon

Gastric Balloon Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

Gastric Balloon Market Material Outlook

  • Silicone
  • Polyurethane
  • Latex

Gastric Balloon Market Distribution Channel Outlook

  • Direct Sales
  • Online Sales
  • Third-party Distributors

Report Scope

MARKET SIZE 20242.386(USD Billion)
MARKET SIZE 20252.552(USD Billion)
MARKET SIZE 20355.011(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)6.98% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesIncreasing demand for non-invasive weight loss solutions drives growth in the Gastric Balloon Market.
Key Market DynamicsRising consumer demand for non-surgical weight loss solutions drives innovation and competition in the gastric balloon market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Leave a Comment

FAQs

What is the projected market valuation of the Gastric Balloon Market by 2035?

The Gastric Balloon Market is projected to reach a valuation of 5.011 USD Billion by 2035.

What was the market valuation of the Gastric Balloon Market in 2024?

In 2024, the Gastric Balloon Market was valued at 2.386 USD Billion.

What is the expected CAGR for the Gastric Balloon Market during the forecast period 2025 - 2035?

The expected CAGR for the Gastric Balloon Market during the forecast period 2025 - 2035 is 6.98%.

Which companies are considered key players in the Gastric Balloon Market?

Key players in the Gastric Balloon Market include Apollo Endosurgery, Medtronic, Obalon Therapeutics, ReShape Lifesciences, Allergan, EndoChoice, Spatz FGIA, and Bariatric Solutions.

What are the projected revenues for the Single Balloon segment by 2035?

The Single Balloon segment is projected to generate revenues of approximately 1.563 USD Billion by 2035.

How does the Dual Balloon segment's revenue projection compare to the Single Balloon segment?

The Dual Balloon segment is expected to generate higher revenues, reaching about 2.086 USD Billion by 2035, compared to the Single Balloon segment.

What is the anticipated revenue for the Silicone material segment by 2035?

The Silicone material segment is anticipated to reach revenues of approximately 1.978 USD Billion by 2035.

Which end-user segment is projected to have the highest revenue by 2035?

The Hospitals end-user segment is projected to have the highest revenue, estimated at 1.973 USD Billion by 2035.

What distribution channel is expected to generate the most revenue in the Gastric Balloon Market by 2035?

The Direct Sales distribution channel is expected to generate the most revenue, reaching approximately 1.978 USD Billion by 2035.

What are the revenue projections for the Triple Balloon segment by 2035?

The Triple Balloon segment is projected to generate revenues of around 1.362 USD Billion by 2035.

What will be the value of the Global Gastric Balloon Market in 2035?

The market is projected to reach a value of 3.5 USD Billion by 2035.

Which region is expected to hold the largest market share in 2024?

North America is expected to hold the largest market share, valued at approximately 0.55 USD Billion in 2024.

What are the anticipated market values for the Intragastric Balloon segment in 2035?

The Intragastric Balloon segment is projected to be valued at 1.65 USD Billion in 2035.

Which key players dominate the Global Gastric Balloon Market?

Major players include ReShape Lifesciences, Apollo Endosurgery, and Allergan among others.

What is the anticipated market size for the Adjustable Balloon segment in 2024?

The Adjustable Balloon segment is expected to be valued at 0.52 USD Billion in 2024.

How fast is the South American market expected to grow by 2035?

The South American market is expected to grow to approximately 0.42 USD Billion by 2035.

What are the projected values for the Dual Balloon segment in 2024 and 2035?

The Dual Balloon segment is expected to be valued at 0.36 USD Billion in 2024 and 0.73 USD Billion in 2035.

What is the market value for the MEA region in 2024?

The MEA region is projected to have a market value of approximately 0.15 USD Billion in 2024.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions